Theranostics Market
Theranostics Market - Global Industry Assessment & Forecast
#
Pages:
196
2023
Apr - 2024
VMR-2451
Segments Covered
By
Products Diagnostic Imaging, Radiopharmaceuticals, IVD/Biomarker Screening, Software & Services
-
By
Application Prostate Cancer, Bone Metastasis, Other Applications
-
By
End User Hospitals & Cancer Care Centers, Theranostics Centers, Research & Academic Centers
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 2091 Million |
 Revenue 2032:
|
USD 6805.1 Million |
 Revenue CAGR
(2024 - 2032): |
14% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
| Sr. No. | Offering | Report Coverage |
| 1. | Market Size | In terms of Revenue (USD Million) |
| 2. | Historic Data | 2018 to 2022 |
| 3. | Forecast Data | 2024 to 2032 |
| 4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
| 5. | Market Attractiveness Analysis | Yes |
| 6. | Segment Analysis | Maximum Segments |
| 7. | Regional Coverage | 5 Regions |
| 8. | Country Coverage | Top 22 Countries |
| 9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
| 10. | Porter’s Five Forces Analysis | Yes. |
| 11. | Value Chain Analysis | Yes |
| 12. | PEST Analysis | Yes |
| 13. | Regulatory Landscape | Yes |
| 14. | Technology Landscape | Yes |
| 15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
| 16. | Top startups to watch out for | Yes |
| 17. | Top 3 Trends to Watch | Yes |
| 18. | Top 3 Strategies Followed by Major Players | Yes |
| 19. | Top 3 Predictions by Vantage Market Research | Yes |
| 20. | Discussion Guide | Yes |
| 21. | Key Primary Respondents - VERBATIM | Yes |
| 22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
| 23. | Others/Miscellaneous | |
Vantage Market
Research | 09-Apr-2024
FAQ
Frequently Asked Question
What is the global demand for Theranostics in terms of revenue?
-
The global Theranostics valued at USD 2091 Million in 2023 and is expected to reach USD 6805.1 Million in 2032 growing at a CAGR of 14%.
Which are the prominent players in the market?
-
The prominent players in the market are GE Healthcare Technologies (U.S.), BAMF Health (U.S.), Siemens Healthcare AG (Germany), Canon Medical Systems Corporation (Japan), Curasight (Denmark), Cardinal Health Inc. (U.S.), Radiopharm Theranotics Ltd. (Australia), Clarity Pharmaceuticals Ltd. (Australia), Point Biopharma Global Inc. (U.S.), Nuview Life Sciences (U.S.),.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 14% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Theranostics include
- Increasing Demand for Personalized Medicine due to the understanding that individuals respond uniquely to treatments based on their genetic makeup, disease characteristics, and lifestyle factors
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Theranostics in 2023.
